DENTSPLY SIRONA (XRAY) Expected to Announce Quarterly Earnings on Thursday

DENTSPLY SIRONA (NASDAQ:XRAY) is anticipated to post its quarterly earnings results before the market opens on Thursday, February 27th. Analysts expect DENTSPLY SIRONA to post earnings of $0.47 per share and revenue of $920.26 million for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $19.05 on Tuesday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA has a 52-week low of $17.21 and a 52-week high of $34.91. The firm has a market cap of $3.79 billion, a price-to-earnings ratio of -9.20, a PEG ratio of 1.80 and a beta of 0.96. The business’s fifty day moving average is $18.91 and its 200 day moving average is $21.64.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, December 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.36%. DENTSPLY SIRONA’s payout ratio is -30.92%.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Wells Fargo & Company assumed coverage on DENTSPLY SIRONA in a research note on Friday, February 14th. They set an “equal weight” rating and a $20.00 price objective on the stock. Jefferies Financial Group lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their target price for the stock from $30.00 to $20.00 in a research note on Thursday, January 23rd. UBS Group decreased their target price on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research note on Tuesday, December 3rd. Morgan Stanley decreased their target price on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research note on Tuesday, December 17th. Finally, Evercore ISI restated an “in-line” rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Ten analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, DENTSPLY SIRONA has an average rating of “Hold” and an average price target of $25.85.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.